These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment. Marksteiner J, Weiss U, Weis C, Laslop A, Fischer-Colbrie R, Humpel C, Feldon J, Fleischhacker WW. Neuroscience; 2001; 104(2):325-33. PubMed ID: 11377837 [Abstract] [Full Text] [Related]
7. Distribution of chromogranins A and B and secretogranin II (secretoneurin) in rat pelvic neurons and vas deferens. Li JY, Leitner B, Winkler H, Dahlström A. Neuroscience; 1998 May; 84(1):281-94. PubMed ID: 9522381 [Abstract] [Full Text] [Related]
8. Co-distribution patterns of chromogranin B-like immunoreactivity with chromogranin A and secretoneurin within the human brainstem. Kato A, Kammen-Jolly K, Fischer-Colbie R, Humpel C, Schrott-Fischer A, Marksteiner J. Brain Res; 2000 Jan 10; 852(2):444-52. PubMed ID: 10678772 [Abstract] [Full Text] [Related]
9. Proteolytic processing, axonal transport and differential distribution of chromogranins A and B, and secretogranin II (secretoneurin) in rat sciatic nerve and spinal cord. Li JY, Leitner B, Lovisetti-Scamihorn P, Winkler H, Dahlström A. Eur J Neurosci; 1999 Feb 10; 11(2):528-44. PubMed ID: 10051753 [Abstract] [Full Text] [Related]
11. Reduction of chromogranin B-like immunoreactivity in distinct subregions of the hippocampus from individuals with schizophrenia. Nowakowski C, Kaufmann WA, Adlassnig C, Maier H, Salimi K, Jellinger KA, Marksteiner J. Schizophr Res; 2002 Nov 01; 58(1):43-53. PubMed ID: 12363389 [Abstract] [Full Text] [Related]
12. Chromogranins as markers of altered hippocampal circuitry in temporal lobe epilepsy. Pirker S, Czech T, Baumgartner C, Maier H, Novak K, Fürtinger S, Fischer-Colbrie R, Sperk G. Ann Neurol; 2001 Aug 01; 50(2):216-26. PubMed ID: 11506405 [Abstract] [Full Text] [Related]
13. Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluid. Kirchmair R, Benzer A, Troger J, Miller C, Marksteiner J, Saria A, Gasser RW, Hogue-Angeletti R, Fischer-Colbrie R, Winkler H. Neuroscience; 1994 Dec 01; 63(4):1179-87. PubMed ID: 7535395 [Abstract] [Full Text] [Related]
14. Temporal lobe epilepsy of the rat: differential expression of mRNAs of chromogranin B, secretogranin II, synaptin/synaptophysin and p65 in subfield of the hippocampus. Mahata SK, Marksteiner J, Sperk G, Mahata M, Gruber B, Fischer-Colbrie R, Winkler H. Brain Res Mol Brain Res; 1992 Nov 01; 16(1-2):1-12. PubMed ID: 1334187 [Abstract] [Full Text] [Related]
15. Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles. Lassmann H, Weiler R, Fischer P, Bancher C, Jellinger K, Floor E, Danielczyk W, Seitelberger F, Winkler H. Neuroscience; 1992 Nov 01; 46(1):1-8. PubMed ID: 1594095 [Abstract] [Full Text] [Related]
16. Secretoneurin: a market in rat hippocampal pathways. Schwarzer C, Marksteiner J, Kroesen S, Kohl C, Sperk G, Winkler H. J Comp Neurol; 1997 Jan 06; 377(1):29-40. PubMed ID: 8986870 [Abstract] [Full Text] [Related]